Table 3 Differences in patient and clinical characteristics between users and non-users of the care booklet
| Â | Non-users | Users | OR (95% CI) |
|---|---|---|---|
N = 273 | N = 79 | ||
Patient characteristics | |||
 Gender (female), n (%) | 182 (66.7) | 58 (73.4) | 1.4 (0.8–2.4) |
 Age (years), mean (SD) | 65.3 (12.2) | 64.7 (9.6) | Δ − 0.7 (−3.7–2.3) |
 Ethnicity (foreign), n (%) | 27 (10.0) | 6 (7.7) | 0.8 (0.3–1.9) |
 Married, n (%) | 181 (69.4) | 64 (84.2) | 2.4 (1.2–4.6)** |
 Level of education (> 12 years), n (%) | 106 (39.9) | 32 (41.6) | 1.1 (0.6–1.8) |
Clinical characteristics | |||
 Disease duration (years), mean (SD) | 17.3 (12.8) | 15.9 (11.2) | Δ −1.5 (−4.6–1.7) |
 Disease activity, RADAI (0–10), mean (SD) | 2.5 (1.9) | 3.0 (2.0) | Δ 0.5 (0.0–1.1)** |
 Activity limitations HAQ-DI (0–3), mean (SD) | 0.9 (0.7) | 1.1 (0.7) | Δ 0.2 (0.1–0.4)** |
 Medication, n (%) | |||
 NSAIDs | 97 (35.5) | 29 (36.7) | 1.0 (0.6–1.7) |
 Corticosteroid | 39 (14.3) | 19 (24.1) | 1.9 (1.0–3.5)** |
 DMARDs | 185 (67.8) | 58 (73.4) | 1.3 (0.8–2.3) |
 Biologicals | 123 (45.1) | 42 (53.2) | 1.4 (0.8–2.3) |
Educational needs, D-ENAT(0–156), mean (SD) | 75.3 (27.5) | 86.0 (26.6) | Δ 9.7 (2.9–16.6)** |
Self-efficacy, GSES, mean (SD) | 32.3 (5.9) | 33.1 (4.1) | Δ 0.8 (−0.6–2.2) |
Illness perceptions, IPQ-R, mean (SD) | |||
 Timeline (6–30) | 24.5 (4.6) | 25.1 (3.9) | Δ 0.6 (−0.5–1.8) |
 Consequences (4–20) | 18.6 (4.7) | 19.8 (4.5) | Δ 1.3 (−0.2–2.3) |
 Timeline cyclical (6–30) | 13.6 (3.6) | 15.1 (3.0) | Δ 1.4 (0.5–2.3)** |
 Personal control (6–30) | 19.2 (3.7) | 19.6 (3.5) | Δ 0.4 (−0.5–1.3) |
 Treatment control (5–25) | 17.8 (3.0) | 17.9 (2.7) | Δ 0.1 (−0.6–0.9) |
 Illness coherence (5–25) | 17.4 (3.7) | 18.0 (3.5) | Δ 0.5 (−0.5–1.4) |
 Emotional representation (6–30) | 13.9 (4.3) | 14.0 (3.6) | Δ 0.1 (−1.0–1.1) |